Pipeline

Channelling RNA interference to cure disease. Providing the tools for precision medicine.

Our programmes

Our upgraded, patient-friendly delivery technology is suitable for applications in a variety of disease settings. Our liver centric pipeline is currently built around two main areas of high unmet need: metabolic and rare diseases.

OurPipeline_Desktop_LightBackground.png (4) OurPipeline_Mobile_LightBackground.png (4)

Please click the programme names below to view our factsheets.

Out-licensed programmes

We out-licensed our siRNA stabilisation chemistry technology (AtuRNAiTM) to Quark Pharmaceuticals, who have progressed drug candidates that use this technology to late clinical trials.

Outlicenced_Desktop_LightBackground.png (1) Outlicenced_Mobile_LightBackground.png (1)

Please click the programme names below to view our factsheets.

  • pipeline-logo1.png
  • pipeline-logo2.png